| Line item | 2025-12-31 FY | 2025-09-29 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.70M | – | $6.12K | – | – |
| R&D | – | – | – | – | – |
| SG&A | $2.70M | – | $140.08K | $83.94K | $27.80K |
| Operating Income | -$2.70M | – | -$140.08K | -$83.94K | – |
| Interest Expense | – | – | $5.79K | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$3.16M | – | -$145.87K | -$83.94K | -$27.80K |
| EPS (basic) | -0.4710 | 0.7500 | -0.0290 | -0.0170 | -0.0060 |
| EPS (diluted) | -0.4710 | – | -0.0290 | -0.0170 | -0.0060 |
| Shares (diluted) | $6.71M | – | $5.00M | $5.00M | $5.00M |